
- Pharmaceutical Commerce - May/June 2011
HDMA honors AmerisoureBergen's Yost with Nexus Award
AmerisourceBergen CEO has had a 37-year career in healthcare distribution
At HDMA’s annual Business & Leadership Conference this week, HDMA’s research arm, the Center for Healthcare Supply Chain Research, and its industry sponsor, Genentech, Inc., honored Yost with the 2011 Nexus Award for Lifetime Achievement. The award recognizes leadership in the healthcare industry and HDMA, as well as community involvement and professional accomplishment.
R. David Yost, has been CEO of AmerisourceBergen since its origin in the merger of AmeriSource Health and Bergen Brunswig Corp. in 2001. He started in the industry in 1974 as a salesman at a predecessor company to AmeriSource, eventually rising to chairman and CEO of AmeriSource. AmerisourceBergen is today a $78-billion company, No. 27 on the Fortune 500. Yost is also on the board of directors of the International Federation of Pharmaceutical Wholesalers, Tyco Corp., the Board of Trustees of Penn Medicine, and a founding director of the United States Air Force Academy Endowment Board. He is a graduate of the Air Force Academy, and has an MBA from UCLA.
“Dave embodies all of the attributes of the Nexus Award through his industry and community leadership,” said HDMA President and CEO John M. Gray. “Throughout his distinguished career he has been a tireless champion for distributors and the customers they serve, yet through all his success and accomplishment, has remained humble and dedicated to his family and community.”
Articles in this issue
over 14 years ago
Introover 14 years ago
What Makes a Pharmaceutical Industry Leader?over 14 years ago
How REMS Affect Pharmaceutical Distribution Processes and Partnersover 14 years ago
Patient-Administered Therapies Drive New Delivery System Designsover 14 years ago
For a Lucky Few, Biopharma Expansion a Reality Againover 14 years ago
Making Pallets a Supply Chain Asset Instead of an Unrecoverable CostNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





